IMC Rare Earths (NYSE American: IMC) — Brazil Fights Back Against China’s Rare Earth Stranglehold
The 1.1 billion metric tonne inferred resource at 1,233 ppm TREO is a large-scale figure that requires contextualisation. This is…
Latigo Biotherapeutics (NASDAQ: LTGO) — A $1.4 Billion Bet on the End of the Opioid Era
The global pain management market was valued at approximately $80–90 billion in 2025 and is projected to reach $120–140 billion…
Londian Wason New Energy (NYSE: FOIL) — The World’s #1 EV Battery Copper Foil Maker Just Listed on Wall Street
Every electric vehicle on the road today — whether it carries a Tesla badge, a VW logo, or a BYD…
Volkswagen AG Pref (VOW3): 10-Year Lows, a 7% Dividend, and a China Problem — Buy, Hold, or Avoid?
Volkswagen Group is Europe's largest carmaker and, alongside Toyota, one of the two largest automakers in the world by volume.…
PureCycle Technologies (NASDAQ: PCT) — The Polypropylene Recycling Revolution at a Commercial Turning Point
PureCycle Technologies holds an exclusive worldwide licence from Procter & Gamble for a patented purification technology that does what no…
One and One Green Technologies (NASDAQ: YDDL) — Profitable Filipino E-Waste Recycler, Down 73%. Value Trap or Hidden Gem?
23% revenue growth to $65.8 million, 81% EPS growth to $0.225, zero debt, a P/E ratio of 8.3× at a…
Suja Life (NASDAQ: SUJA) — America’s Organic Juice Leader Lost 67% Since IPO. Is $5.88 the Bottom?
The brand is genuine: Suja Organic has 30,000+ retail distribution points, strong brand recognition in the natural foods channel, and…
The 14 Worst-Performing IPOs of Q2 2026: Which Ones Still Deserve a Second Look?
These five, in our view, have fallen for reasons that look more like valuation resets or technical/liquidity effects than deteriorating…
Apnimed (NASDAQ: APMD) — The First Pill for Sleep Apnea. 936 Million Patients. One Phase 3 Drug.
The global sleep apnea device and drug market is estimated at $9–11 billion annually, with pharma analysts projecting a successfully-approved…
Scribe Therapeutics (NASDAQ: SCTX) — Jennifer Doudna’s CRISPR Company Goes Public. What Investors Need to Know.
The AstraZeneca partnership, announced before the IPO, is the company's most significant external validation. AZ committed up to $420 million…
Standard Nuclear (NYSE: STDN) — America’s Only TRISO Fuel Producer Hit the NYSE. Then Lost 45% in 10 Days.
The most credible near-term data point in the STDN story is its disclosed contract backlog: $245 million total, of which…
The SpaceX Effect: Is the Space-Stock Selloff Really About SpaceX?
Since peaking at $225.64 on June 16, 2026 — five days after the largest IPO in history — SpaceX (NASDAQ:…
Bending Spoons (NASDAQ: BSP) — Europe’s Most Unusual Tech Company Just Hit Wall Street
Bending Spoons raised $1.68 billion on July 1, 2026, making it the largest Italian tech IPO in history and one…
SK Hynix (NASDAQ: SKHY) — The World’s HBM Leader Hits Wall Street. $26.5B and a 14% First-Day Pop.
Revenue jumped 198% year-over-year to approximately $34.5 billion for a single quarter. The gross margin was 79.3%. The operating margin…
Sinda Ltd. (NYSE: SIND) IPO Analysis — 369 Million Silver Ounces Hidden Under Mexican Clay. Is This the Last Great Silver Discovery?
Sinda Ltd. raised $213 million from its IPO plus $110 million from Fresnillo, the world's top primary silver producer, in…
Karman Holdings (NYSE: KRMN) — Missiles, Hypersonics & a 45% Pullback: Is This the Best Defense Entry Point of 2026
Revenue is growing at 50%. Karman Holdings is one of the most genuinely interesting defense stories in the public markets…
Applied Aerospace & Defense (NYSE: AADX) IPO Analysis — Defense Hardware Is Back, But Is the Stock a Buy?
A $650 million IPO, a $1.1 billion contract backlog, and customers including SpaceX, Boeing, Lockheed Martin, and NASA — and…
DPC Holdings (NYSE: DPC) IPO Analysis — 246 Years of Aerospace Heritage, One Very Hot Debut
The $930 million order backlog as of March 31, 2026 is direct evidence of this embedded position. It is not…
Deep Fission (NASDAQ: FISN) IPO Analysis — A Nuclear Reactor Buried One Mile Underground. Is This the Boldest Energy Bet of 2026?
The most credible near-term customers are hyperscale data center operators. The AI infrastructure buildout has created a power demand crisis…
Parabilis Medicines (NASDAQ: PBLS) IPO Analysis — Revolutionary Cancer Technology or Another High-Risk Biotech Bet?
A company can be worth billions of dollars without selling a single commercial product, while one successful clinical trial can…